Combination use of platelets and recombinant activated factor VII for increased hemostasis during acute type a dissection operations

BACKGROUND: Refractory blood loss is a common problem in surgeries for acute type A aortic dissections. Significant evidence has supported the benefit of using recombinant activated factor VII (rFVIIa) to control of intractable bleeding in patients after cardiac surgery. In this prospective clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Wen, Xuan, Chengluan, Ma, Guojia, Zhang, Liang, Dong, Ning, Wang, Zijian, Xu, Rihao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4156631/
https://www.ncbi.nlm.nih.gov/pubmed/25179738
http://dx.doi.org/10.1186/s13019-014-0156-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4156631/
https://www.ncbi.nlm.nih.gov/pubmed/25179738
http://dx.doi.org/10.1186/s13019-014-0156-y

Ejemplares similares